Covid19 Clinical Trial - Exercise Intervention Using mHealth in Patients

Status Recruiting

Clinical Trial Summary

Post-Acute Syndrome COVID-19 is a disease resulting from infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is estimated that between 10 and 35% of infected persons suffer symptoms afterwards, and in hospitalized patients it can reach 85%. These sequelae have individual, social and economic repercussions, so effective rehabilitation alternatives are necessary. Physical exercise is recommended as rehabilitation for these patients. Moreover, the implementation of m-Health supported interventions is a proven alternative in patients with Post-Acute COVID-19 Syndrome or other conditions, which improves therapeutic adherence and patient autonomy. Therefore, the development and evaluation of the effectiveness of an exercise-based m-Health system for application in patients with Post-Acute COVID-19 Syndrome responds to a need. Our hypothesis is that a mobile health technology based on physical exercise recommendations for patients with Post-Acute COVID-19 Syndrome will improve fatigue, physical fitness, post-exertional dyspnea, pain intensity, anxiety, depression, cognitive function, and quality of life. Therefore, this project aims to evaluate the efficacy of the mobile health technology system (COVIDReApp) based on physical exercise recommendations for patients with COVID-19 Post-Acute Syndrome based on its results on fatigue, physical condition, post-exertional dyspnea, pain intensity, anxiety and depression, cognitive function and quality of life. The achievement of the present project will serve to analyze the benefits of a physical exercise program in patients with COVID-19 Post-Acute Syndrome and identify those patients in whom the benefits will be greatest and whose implementation will have the highest priority.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05725538
Study type	Interventional
Source	University of Cadiz
Contact	Jose A. Moral-Munoz, PhD
Phone	956 015699
Email	joseantonio.moral@uca.es
Status	Recruiting
Phase	N/A
Start date	March 15, 2023
Completion date	September 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05926505` - Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome	Phase 2/Phase 3
Recruiting	`NCT04872309` - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Completed	`NCT05552612` - Health-related Quality of Life and Long COVID
Completed	`NCT05531019` - COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A	N/A
Not yet recruiting	`NCT04949386` - Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.	Phase 2
Recruiting	`NCT06118112` - Living With Long COVID: LONGCOVID-EXPERIENCE
Completed	`NCT05185674` - Sociodemographic, Clinical, Quality of Life and Health Care Conditions in COVID-19 Survivors.
Active, not recruiting	`NCT05965752` - RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms	N/A
Active, not recruiting	`NCT05965739` - RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms	N/A
Completed	`NCT05812209` - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Recruiting	`NCT05606211` - Pain in Long COVID-19: The Role of Sleep
Active, not recruiting	`NCT05713266` - Using Data From a Multisensor Rapid Health Assessment Device to Predict Decompensation in Long COVID (AIDI)
Completed	`NCT05679505` - Vagus Nerve Stimulation for Post-COVID Syndrome	N/A
Completed	`NCT05601180` - Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID.	N/A
Not yet recruiting	`NCT06045338` - Mind Body Intervention for Long COVID	N/A
Recruiting	`NCT06091358` - Inspiratory Muscle Training in People With Long COVID-19- A Pilot Investigation.	N/A
Recruiting	`NCT05566392` - Longterm Influence of Pediatric Long COVID Syndrome
Recruiting	`NCT05855369` - Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss	Phase 2/Phase 3
Recruiting	`NCT05572346` - Digital App for Telerehabilitation in Respiratory Diseases
Recruiting	`NCT06316843` - Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Exercise Intervention Using mHealth in Patients With Post-Acute COVID-19 Syndrome: a Randomized Clinical Trial — COVIDReApp

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms